Powder: -20°C for 3 years
In solvent: -80°C for 2 years
GNF-6231 is a potent, selective, and orally bioavailable Porcupine inhibitor that blocks Wnt signaling.
Description | GNF-6231 is a potent, selective, and orally bioavailable Porcupine inhibitor that blocks Wnt signaling. |
In vitro | GNF-6231 shows IC50s of greater than 10 μM on all CYP isoforms tested[1]. |
In vivo | GNF-6231 has favorable potency and a PK profile across preclinical species upon oral administration. The reference for orally in MMTV-Wnt1 tumor-bearing mice is dosed at 3 mg/kg. GNF-6231 showed very robust dose-related antitumor efficacy[1]. |
Molecular Weight | 448.49 |
Formula | C24H25FN6O2 |
CAS No. | 1243245-18-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 36mg/mL (80.3mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GNF-6231 1243245-18-2 其他 Others GNF6231 GNF 6231 Inhibitor inhibitor inhibit